NASDAQ · HURA
TuHURA Biosciences, Inc.
$1.90-$0.16 (-7.77%)
TuHURA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.61% below the high.
Loading market information…
OTC · VCBDQ · USD
Stock price
Quote as of Aug 4, 2023, 07:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Vitalibis, Inc. is a technology-driven company that specializes in developing and creating phytocannabinoid-rich hemp products, including those infused with cannabidiol (CBD). Beyond these, they also formulate personal care items and nutritional supplements. The company markets and sells these consumer goods directly under its proprietary Vitalibis brand. A key product in their portfolio is a water-soluble, phytocannabinoid-rich hemp powder. Originally established in 2014, the company was initially known as Sheng Ying Entertainment Corp. It subsequently rebranded to Vitalibis, Inc. in February 2018. Its operations are based in Las Vegas, Nevada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.90-$0.16 (-7.77%)
TuHURA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.61% below the high.
£5.66-£1.14 (-16.76%)
Hemogenyx Pharmaceuticals Plc’s quoted price sits in the lower half of its reported 52-week range, 53.61% below the high.
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
$0.00$0.00 (0.0%)
CuraScientific Corp: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
Better Plant Sciences Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.08-$0.00 (-2.33%)
Kiromic BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.56% below the high.
$0.00+$0.00 (+179,899.98%)
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
$0.00+$0.00 (+9,900.0%)
MedMen Enterprises Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
